CA1190224A
(en )
1985-07-09
Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists
CA2977521C
(en )
2024-03-19
1-(aryl)-3-(heteroaryl) urea compounds and their use as olig2 inhibitors
DE2362409B2
(de )
1979-08-09
NJ4'<m-Phenylen)-dioxamidsäuren und deren Derivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
GB1561345A
(en )
1980-02-20
8 - azapuring - 6 - ones
WO1993024459A1
(en )
1993-12-09
Quaternary pyridinium compounds
JPH0260671B2
(enExample )
1990-12-17
PL88932B1
(enExample )
1976-10-30
WO1995021822A1
(en )
1995-08-17
Pyridinium compounds
GB1587128A
(en )
1981-04-01
Benzothiazepine derivatives
EP0099122A2
(en )
1984-01-25
Compositions comprising pepstatin and an histamine H2-receptor antagonist having an enhanced antiulcer activity
ES2207325T3
(es )
2004-05-16
((aminoiminomethil) amino) alcanocarboxamidas y sus aplicaciones terapeuticas.
DE2525250C2
(de )
1985-02-14
N,N'-Phenylendioxamsäureester, Verfahren zu deren Herstellung sowie pharmazeutische Präparate, die diese Verbindungen enthalten
SE452007B
(sv )
1987-11-09
Amidinosubstituerade ureaforeningar och en farmaceutisk komposition for behandling av gastrointestinala eller kardiovaskulera rubbningar
JPH02502534A
(ja )
1990-08-16
1‐メチル‐β‐オキソ‐α‐(フェニルカルバモイル)‐2‐ピロールプロピオニトリルのトロメタミン塩
IL38451A
(en )
1974-12-31
Antiviral ureidophenyl-guanidine compounds
PL91733B1
(enExample )
1977-03-31
US2192828A
(en )
1940-03-05
Therapeutic agent
NO117362B
(enExample )
1969-08-04
PL141942B1
(en )
1987-09-30
Process for preparing novel,basic oxime ethers
US5489609A
(en )
1996-02-06
2-aminoethanesulfonic acid zinc complex compound
PL91732B1
(enExample )
1977-03-31
US3714364A
(en )
1973-01-30
Process for lowering blood sugar levels
TW200930361A
(en )
2009-07-16
Imidazolidinone and imidazolidinethione derivatives
PL98956B1
(pl )
1978-06-30
Sposob wytwarzania nowych pochodnych guanidyny
CH629490A5
(en )
1982-04-30
Processes for preparing the novel N,N'-bis-(3-methylthiazolidin-2-ylidene)succinamide.